What are the diagnostic criteria for acute‑on‑chronic liver failure (ACLF), decompensated chronic liver disease (DCLD), and alcoholic liver disease (ALD)?

Diagnostic Criteria for ACLF, DCLD, and Alcoholic Liver Disease

For ACLF diagnosis, you must identify three mandatory components: acute deterioration with elevated bilirubin and INR in chronic liver disease, plus at least one extrahepatic organ failure (neurologic, circulatory, respiratory, or renal). 1

Acute-on-Chronic Liver Failure (ACLF)

Core Diagnostic Requirements

The 2024 AASLD guidance establishes minimum critical components that must ALL be present 1:

• Acute onset with rapid clinical deterioration in a patient with underlying chronic liver disease (with or without established cirrhosis) 1
• Liver failure defined by:
  • Elevated bilirubin (cutoffs of 5-12 mg/dL have been examined, though optimal thresholds remain debated) 1
  • Elevated INR (typically ≥1.5, though ranges of 1.5-2.5 have been used) 1
• At least one extrahepatic organ failure from: neurologic, circulatory, respiratory, or renal systems 1

Regional Definition Variations

Three major geographic definitions exist, capturing different disease stages 1:

• APASL (Asian): Identifies early-stage disease; more sensitive but less specific, as most patients survive beyond 28 days 1
• EASL-CLIF (European): Captures intermediate stages (ACLF-1, ACLF-2) and late stage (ACLF-3) with grading based on number of organ failures 1, 2
  • ACLF-1: Single renal failure OR single non-renal organ failure with renal/cerebral dysfunction 3
  • ACLF-2: Two organ failures 3
  • ACLF-3: Three or more organ failures (28-day mortality 23-74%) 3
• NACSELD (North American): Defines only late-stage disease requiring ≥2 extrahepatic organ failures; often preterminal 1

Organ Failure Assessment

Use the CLIF-SOFA or CLIF-OF score to define organ failures 3, 2:

• Liver failure
• Renal failure
• Coagulation failure
• Cerebral failure
• Respiratory failure
• Circulatory failure

Clinical Context

ACLF develops in approximately one-third of hospitalized patients with acute decompensation 3, 2. Precipitating events may be liver-related (alcohol-associated hepatitis, viral hepatitis, drug-induced hepatitis) or non-liver-related (surgery, infection), though often no precipitant is identified 1.

Distinguishing features from simple decompensation include 2:

• Younger age
• Higher frequency of bacterial infections
• Elevated leukocyte counts and C-reactive protein
• Higher systemic inflammation markers 2

Decompensated Chronic Liver Disease (DCLD)

Decompensated cirrhosis manifests with complications of portal hypertension without the organ failure criteria of ACLF 1.

Key Features

• Clinical manifestations: Ascites, variceal bleeding, hepatic encephalopathy, jaundice 1
• Absence of multiple organ failures distinguishes this from ACLF 3, 2
• 28-day mortality in decompensated cirrhosis without ACLF is approximately 1.9%, compared to 30-34% with ACLF 2

Pre-ACLF State

A subset of decompensated patients at higher ACLF risk ("pre-ACLF") demonstrate 1:

• Higher frequency of complications at presentation
• Elevated inflammatory markers (CRP, WBC)
• Higher severity scores (CLIF-C, MELD, MELD-Na) 1

Alcoholic (Alcohol-Associated) Liver Disease

The terminology has shifted from "alcoholic" to "alcohol-associated" to reduce stigma, retaining familiar abbreviations (ALD, ASH, AC), though "alcoholic hepatitis" persists in common usage 4.

Disease Spectrum

ALD encompasses a continuum 4, 5:

• Hepatic steatosis (fatty liver): Early, often asymptomatic stage
• Alcohol-associated steatohepatitis (ASH): Inflammatory liver injury
• Alcohol-associated cirrhosis (AC): Advanced fibrosis with architectural distortion
• Alcoholic hepatitis (AH): Acute inflammatory syndrome with rapid jaundice onset 4, 6

Diagnostic Requirements

Diagnosis requires 4, 6:

• Documentation of chronic heavy alcohol use (specific thresholds vary but generally >2-3 drinks/day for women, >3-4 drinks/day for men over years)
• Exclusion of other liver disease etiologies 6
• Clinical-histologic correlation when biopsy performed 4

Alcoholic Hepatitis Specific Criteria

AH presents with 4, 5:

• Rapid onset or worsening of jaundice (bilirubin typically >3 mg/dL)
• Recent heavy alcohol use (typically within 8 weeks)
• May progress to ACLF with 20-50% one-month mortality in severe cases 4, 5
• Model for End-Stage Liver Disease (MELD) score >20 defines severe disease 5

Risk Factors for Progression

Factors accelerating ALD progression include 4:

• Female sex
• Genetic susceptibility
• Dietary factors
• Comorbid liver diseases (viral hepatitis, NAFLD, iron overload) 4

Alcohol-Associated Hepatitis as ACLF Precipitant

AH is a common trigger for ACLF and uniquely affects systemic immune responses 7. When AH precipitates ACLF, patients demonstrate the combined features of both conditions: acute hepatic inflammation with jaundice plus extrahepatic organ failures meeting ACLF criteria 8, 7.

Clinical Pitfalls

Common diagnostic errors to avoid:

• Do not diagnose ACLF based solely on elevated bilirubin and INR—extrahepatic organ failure is mandatory 1
• Do not confuse simple decompensation with ACLF—the presence of systemic inflammation and organ failures distinguishes them 2
• Do not overlook precipitating events—bacterial infections are frequently present and require aggressive treatment 2
• Do not assume all jaundiced patients with alcohol use have AH—exclude other causes and consider biopsy when diagnosis is uncertain 4, 6